| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |